Healthcare Supply Chain Management Market Analysis & Forecast: 2026-2033
The Healthcare Supply Chain Management Market size is anticipated to grow at a CAGR of 8.2% with USD 45 Bn in 2026 and is expected to reach USD 78 Bn in 2033. The primary drivers are defined by the rising hospital procurement complexity, drug shortage management, need for real-time inventory visibility, cold chain monitoring, DSCSA serialization compliance, and adoption of AI-enabled supply chain platforms. The U.S. healthcare system spent USD 5.3 trillion in 2024, while hospital expenditure reached USD 1,634.7 Bn. This supports the higher demand for cost-control and supply chain optimization solutions.
On the basis of model, the make-to-stock segment is projected to account for the largest Healthcare Supply Chain Management Market share of 50.2% in 2026. The segment’s growth is owing to its suitability for high-volume healthcare demand, particularly pharmaceuticals, consumables, and emergency care products requiring continuous availability.
CMS also reports that prescription drug spending grew 7.9% in 2024, reinforcing stable and predictable consumption patterns supporting make-to-stock supply chains.
In May 2026, Medline launched the AI-powered Mpower digital control tower to help healthcare providers predict, respond to, and resolve supply chain disruptions before they impact patient care. The platform combines predictive analytics, real-time visibility, and workflow automation to improve inventory management efficiency and strengthen the supply chain resilience in the healthcare systems.
To learn more about this report, Request Free Sample
On the basis of function, the inventory management and procurement segment lead with a major 31.8% share in 2026. The growth is owing to the rising drug shortage prevention efforts and increasing regulatory oversight across healthcare systems.
According to the U.S. FDA, there were 55 new drug shortages in 2023. This reinforces the need for real-time inventory visibility in hospitals.
In September 2024, Owens & Minor announced a partnership with Google Cloud to enhance its QSight platform using AI as well as cloud technology for the hospital inventory management. The collaboration aims to improve real-time visibility, optimize management of medical supplies and implants, and enable future innovations that minimize costs and improve supply chain efficiency in the healthcare systems.
AI-based supply chain resilience is becoming critical for the U.S. Healthcare Supply Chain Management Market as hospitals, distributors, and manufacturers face persistent medicine availability risks.
According to USP analysis of FDA shortage data, nearly 75 drugs were in shortage at the end of 2025. Thus highlighting the ongoing vulnerabilities in medicine availability across both critical care as well as specialty therapeutics.
In May 2026, Global Healthcare Exchange (GHX) launched an AI-powered orchestration layer to help healthcare supply chain leaders detect disruptions early, coordinate decisions faster, and act proactively. The platform aims to reduce workflow inefficiencies by connecting data, automating processes, and improving collaboration between providers and suppliers to strengthen the supply chain resilience.
Advanced transaction integrity through 8-way EDI matching is emerging as a major breakthrough in the Healthcare Supply Chain Management Market. The hospitals are seeking tighter control over purchase orders, contracts, receipts, invoices, rebates, and item-master data.
The need for stronger transaction validation is further reinforced by the scale of federally regulated drug purchasing systems. According to the U.S. Health Resources and Services Administration (HRSA), the 340B covered entities purchased a record USD 81.4 billion in outpatient drugs in 2024. This highlights the growing complexity of pricing, rebate reconciliation, as well as the contract compliance in the healthcare procurement networks.
In January 2026, Veradigm and Meperia announced an industry-first 8-way match EDI platform to improve the healthcare supply chain integrity. The cloud-based solution enhances data accuracy, contract compliance, and transaction transparency by automatically validating healthcare purchases against multiple records, thereby minimizing errors and preventing overpayments.
|
Current Event |
Description and its Impact |
|
DSCSA Electronic Drug Traceability Implementation in the U.S. |
|
|
FDA Quality Management System Regulation Effective in 2026 |
|
Uncover macros and micros vetted on 75+ parameters: Get instant access to report
To learn more about this report, Request Free Sample
The North America region accounts for 39.5% of the market share in 2026. The region’s growth is owing to persistent drug shortages, strong regulatory oversight, and rapid digitalization of procurement systems across hospitals and distributors.
The American Society of Health-System Pharmacists documented 270 active drug shortages in March 2025. This highlights the the need for stronger inventory visibility, demand forecasting, as well as supplier-risk monitoring.
Canada also reported 2,588 new drug shortage reports in 2024–25, with 1,772 reports still active by year-end, thereby strengthening the demand for digital supply continuity tools.
In November 2025, Diversis Capital announced a merger of Genesis Automation Healthcare, Meperia, and Kermit to create an end-to-end healthcare supply chain and inventory management platform. The combined platform aims to unify procurement, inventory, and analytics systems, reducing waste, improving contract compliance, and delivering over $1 billion in annual procurement savings across hospitals and health systems.
Asia Pacificis expected to witness strong growth in Healthcare Supply Chain Management Market over the forecast period. The region’s growth is owing to the large public medicine-distribution networks, shortage-management pressure, and rapid digitization of drug logistics.
In India, PMBJP had opened 16,912 Jan Aushadhi Kendras by 30 June 2025, with a basket of 2,110 medicines and 315 surgicals/medical consumables/devices, creating strong demand for centralized procurement, warehouse management, batch tracking, and distributor visibility.
Australia also shows the need for resilient systems: TGA reported that manufacturing issues accounted for 63% of shortage reasons in 2023, while sponsors must report shortage dates, reasons, stock situation, expected impact, and proposed management actions.
A key development is India’s end-to-end IT-enabled PMBJP supply chain, including one central warehouse, four regional warehouses, 39 distributors, and regular monitoring of 400 fast-moving products, supporting real-time availability and last-mile access across hospitals, pharmacies, public health centers, and rural access points.
The United States Healthcare Supply Chain Management Market is driven by supply resilience, shortage visibility, and domestic manufacturing initiatives. The FDA’s 2024 Drug Shortages Report recorded 1,459 potential drug and biological product shortage notifications from 151 manufacturers. This highlights the need for real-time inventory tracking, supplier-risk monitoring, demand forecasting, as well as automated shortage-response workflows.
In March 2026, HHS-ASPR awarded an additional USD 8.3 million to API Innovation Center to expand U.S. API manufacturing capacity for propofol and metoprolol, thus aiming to build the first end-to-end domestic metoprolol supply chain in decades. Such actions push hospitals, distributors, and manufacturers toward integrated supply-chain platforms.
China is expected to show strong growth in the Healthcare Supply Chain Management Market. The trend is driven by tighter drug traceability, insurance-fund supervision, and rising need for compliant inventory visibility across hospitals, pharmacies, distributors, and device importers. In 2025, Chinese authorities used drug-tracking codes to inspect 124,700 medical and pharmaceutical institutions and punished 39,100 violators, showing rapid adoption of digital monitoring in healthcare logistics.
In January 2026, HTDK supported the China launch of STAAR Surgical’s EVO+ ICL (V5) with regulatory-compliant distribution, import-export, inventory management, after-sales service, and nationwide supply-chain operations, strengthening demand for integrated SCM platforms.
Some of the major key players in Healthcare Supply Chain Management Market are Oracle, SAP SE, Infor., McKesson Corporation, Tecsys Inc., Global Healthcare Exchange, LLC., Cardinal Health, Epicor Software Corporation, LLamasoft Inc., Manhattan Associates, Jump Technologies, Inc., Blue Yonder Group, Inc., Cerner Corporation, Logi-Tag Systems, Picis Clinical Solutions, Inc., Premier, HYBRENT, INC, and Arvato Supply Chain Solutions SE.
| Report Coverage | Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 45 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 8.2% | 2033 Value Projection: | USD 78 Bn |
| Geographies covered: |
|
||
| Segments covered: |
|
||
| Companies covered: |
Oracle, SAP SE, Infor., McKesson Corporation, Tecsys Inc., Global Healthcare Exchange, LLC., Cardinal Health, Epicor Software Corporation, LLamasoft Inc., Manhattan Associates, Jump Technologies, Inc., Blue Yonder Group, Inc., Cerner Corporation, Logi-Tag Systems, Picis Clinical Solutions, Inc., Premier, HYBRENT, INC, and Arvato Supply Chain Solutions SE |
||
| Growth Drivers: |
|
||
| Restraints & Challenges: |
|
||
Uncover macros and micros vetted on 75+ parameters: Get instant access to report
Share
Share
Komal Dighe is a Management Consultant with over 8 years of experience in market research and consulting. She excels in managing and delivering high-quality insights and solutions in Health-tech Consulting reports. Her expertise encompasses conducting both primary and secondary research, effectively addressing client requirements, and excelling in market estimation and forecast. Her comprehensive approach ensures that clients receive thorough and accurate analyses, enabling them to make informed decisions and capitalize on market opportunities.
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients
